SONN icon

Sonnet BioTherapeutics
SONN

Overview Fund Trends Analyst Outlook Journalist POV

9 hedge funds and large institutions have $1.67M invested in Sonnet BioTherapeutics in 2021 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

less funds holding

Funds holding: →

83% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 6

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$895K
2
+$99K
3
+$11.4K

Top Sellers

1
-$255K
2
-$146K
3
-$118K
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$46K
5
Jane Street
Jane Street
New York
-$39K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.11M
2
$290K
3
$99K
4
$71K
5
$53K
6
$24K
7
$17K
8
$3K
9
$2K
10
$2K
11
–
12
–
13
–
14
–
15
–
16
–
17
–